Colestipol (Colestid)

09/01/1976 - "Colestipol seems to be an effective and safe drug in the treatment of the famiial type II hyperlipoproteinemia, without escape phenonmenon."
09/01/1976 - "Colestipol in familial type II hyperlipoproteinemia: a three-year trial."
03/04/1992 - "[Colestipol in the treatment of heterozygous familial hypercholesterolemia]."
01/01/1982 - ""Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia."
02/01/1979 - "Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia."

01/01/1973 - "Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits."
06/19/1987 - "Atherosclerosis regression, as indicated by perceptible improvement in overall coronary status, occurred in 16.2% of colestipol-niacin treated vs 2.4% placebo treated (P = .002)."
02/01/2004 - "A 2-year follow-up study of 153 patients with femoral atherosclerosis treated with colestipol-niacin demonstrated a decreased progression of angiographically assessed femoral atherosclerosis (p < 0.02). "
01/01/1996 - "With all three end points, the benefit of colestipol/niacin treatment on coronary artery atherosclerosis has been reported. "
02/01/1991 - "Effects of colestipol-niacin therapy on human femoral atherosclerosis."

12/19/1990 - "Beneficial effects of colestipol-niacin on coronary atherosclerosis. "
11/20/1987 - "Colestipol-niacin therapy and coronary atherosclerosis."
06/19/1987 - "Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts."
06/27/1986 - "Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease."
06/01/1988 - "Studies that used cholestyramine and the combination of colestipol and niacin resulted in decreased progression of coronary artery disease. "

01/01/1975 - "Colestipol HCl appears to be a safe and effective treatment for hypercholesterolemia; tolerance does not seem to develop."
07/15/1992 - "A double-blind, placebo-controlled, randomized trial of 3 low doses of colestipol hydrochloride was conducted in women and men with moderate hypercholesterolemia. "
03/01/1978 - "Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study."
09/01/1988 - "The use of diet and low colestipol doses may be considered in patients with moderate hypercholesterolemia who do not respond to diet alone."
06/09/1977 - "[Colestipol by hypercholesteremia in diabetics]."

06/01/2000 - "Among 133 subjects with baseline and on-trial coronary angiography and carotid ultrasonography, colestipol-niacin treatment significantly reduced progression of atherosclerosis by both end point measures (2-year average change in percent diameter stenosis by coronary angiography and rate of change in carotid IMT). "
01/01/2007 - "In the FATS study, the severity of stenosis after 2.5 years in recipients of lovastatin plus colestipol was reduced by 2.8% compared with placebo, while the frequency of lesion progression was halved and the frequency of lesion regression was tripled. "
01/01/2007 - "Three randomised, controlled, secondary prevention trials have demonstrated that in patients with coronary artery disease, treatment with lovastatin 20-80 mg/day alone or in combination with colestipol for 2-2.5 years reduced the severity of stenosis and/or slowed or reversed the progression of atherosclerosis, as assessed by angiography. "